Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children: "minimal risk" "minor increment of minimal risk" and "disorder or condition" January 28, 2001 A cornerstone of the Declaration of Helsinki (adopted by the World Medical Association in 1964, and reaffirmed on Oct. 2000) is the distinction between research…
Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…
Researcher To Be Sacked After Reporting High Rates of ADHD – BMJ Sun, 10 Apr 2005 The BMJ reports that Dr. Gretchen LeFever, a clinical psychologist and professor at Eastern Virginia Medical School, whose published reports (since 1995) have raised the alarm about a spiraling increase in elementary school children…
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29 Jun 2005 The FDA is finally taking note of the fact that many drugs prescribed for the treatment of psychiatric problems are CAUSING serious psychiatric and cardiovascular problems in children and adolescents !…
NIH Conflict of Interest Rules_”Option of Corruption”_ children victimized Tue, 18 May 2004 Lawmakers accused leaders of the National Institutes of Health of encouraging “the option of corruption.” NIH medical researchers, who receive the highest salaries in government, think they, unlike others, are entitled to moonlight while employed at taxpayers…
October 1, 2001 Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments. ___________________________________________________…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
European Medicines Agency finalises review of antidepressants in children / adolescents Tue, 26 Apr 2005 The European Medicines Agency (EMA) has issued a press release recommending warnings about the increased risk of suicide attempts and hostility for children and adolescents prescribed an SSRI or SNRI antidepressant –and added warnings about…
Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse Fri, 11 Mar 2005 Parents and public health policy makers have cause for concern about the finding of a study conducted at the University of Texas, MD Anderson Cancer Center. WebMD reports that all 12 children…
“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004 Forest Laboratories, manufacturer of the antidepressant, Celexa / Lexapro, is the latest manufacturer to issue warnings (April 2004) about the possibility that “patients with major depressive disorder, both adult and pediatric, may experience…
July 25, 2002 US Drug Usage Explodes_327% increase in Children FYI The National Center for Health Statistics analyzed data gathered by the National Ambulatory Medical Care Survey (office-based physicians’ data). The findings: Drug prescriptions increased 34% between 1985-1999; Psychiatrists had the largest increase in drug mentions, jumping to 178 drugs…
What to do about the ADHD epidemic William B. Carey, M.D. American Academy of Pediatrics Section on Developmental and Behavioral Pediatrics Newsletter, Autumn 2003, Pages 6-7 In the last two decades the United States has experienced a great increase in the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and…
